Ledger.Open graph →
SEC Form D · filed August 13, 2019

RECURSION PHARMACEUTICALS, INC

Offering
$122.1M
Sold
$122.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Jonathan S. Katz · New York, NYDirectorChrista Dorrego · New York, NYDirectorGrant P. Gund · Needham, MADirectorKyu Jo · New York, NYDirectorWilliam R. Cowen · Needham, MAExec · Director · PromoterVasudev Kulkarni · New York, NYDirectorSteve M. Ritchie · Louisville, KYDirectorPaul Conley · San Diego, CADirectorAthena Demos · Van Nuys, CAExec · Director · PromoterMatthew B. Popoli · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗